Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

ClinicalTrials.gov ID: NCT07686263

Public ClinicalTrials.gov record NCT07686263. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 8:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Double-blind, Placebo-controlled Randomized Withdrawal Maintenance Trial of KarXT Treatment in Participants With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the relapse prevention of KarXT in the treatment of participants with Schizophrenia

Study identification

NCT ID
NCT07686263
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
472 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2, 2026
Primary completion
Mar 2, 2029
Completion
Mar 2, 2029
Last update posted
Jul 6, 2026

2026 – 2029

United States locations

U.S. sites
33
U.S. states
10
U.S. cities
29
Facility City State ZIP Site status
Local Institution - 0133 Bentonville Arkansas 72712
Local Institution - 0154 Bentonville Arkansas 72712
Local Institution - 0139 Little Rock Arkansas 72204
Local Institution - 0021 Little Rock Arkansas 72211
Local Institution - 0153 Rogers Arkansas 72758
Local Institution - 0190 Anaheim California 92805
Local Institution - 0040 Bellflower California 90706
Local Institution - 0188 Chino California 91710
Local Institution - 0032 Culver City California 90230
Local Institution - 0037 Garden Grove California 92845
Local Institution - 0068 La Habra California 90631
Local Institution - 0128 Lemon Grove California 91945
Local Institution - 0187 Montclair California 91763
Local Institution - 0151 Orange California 92868
Local Institution - 0030 Pico Rivera California 90660
Local Institution - 0185 Redlands California 92373
Local Institution - 0186 Riverside California 92506
Local Institution - 0149 Hollywood Florida 33021
Local Institution - 0145 Hollywood Florida 33024
Local Institution - 0075 Miami Florida 33135
Local Institution - 0054 Miami Lakes Florida 33016
Local Institution - 0134 Miami Springs Florida 33166
Local Institution - 0044 West Palm Beach Florida 33407
Local Institution - 0166 Atlanta Georgia 30331
Local Institution - 0070 Sandy Springs Georgia 30328
Local Institution - 0189 Savannah Georgia 31405
Local Institution - 0067 Chicago Illinois 60640-5017
Local Institution - 0056 Chicago Illinois 60641
Local Institution - 0023 St Louis Missouri 63141
Local Institution - 0135 Buffalo New York 14215
Local Institution - 0183 Cincinnati Ohio 45219
Local Institution - 0047 Oklahoma City Oklahoma 73112
Local Institution - 0049 Austin Texas 78754

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07686263, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 6, 2026 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07686263 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →